[go: up one dir, main page]

FI952203A0 - Sykloheksaanijohdannaiset, menetelmä niiden valmistamiseksi ja yhdisteiden käyttö sairauksien hoitamiseksi - Google Patents

Sykloheksaanijohdannaiset, menetelmä niiden valmistamiseksi ja yhdisteiden käyttö sairauksien hoitamiseksi

Info

Publication number
FI952203A0
FI952203A0 FI952203A FI952203A FI952203A0 FI 952203 A0 FI952203 A0 FI 952203A0 FI 952203 A FI952203 A FI 952203A FI 952203 A FI952203 A FI 952203A FI 952203 A0 FI952203 A0 FI 952203A0
Authority
FI
Finland
Prior art keywords
cyclohexanedrate
diseases
compounds
preparation
treatment
Prior art date
Application number
FI952203A
Other languages
English (en)
Swedish (sv)
Other versions
FI110097B (fi
FI952203L (fi
Inventor
Horst Hemmerle
Gerrit Schubert
Hans-Joerg Burger
Andreas Herling
Suad Efendic
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI952203A0 publication Critical patent/FI952203A0/fi
Publication of FI952203L publication Critical patent/FI952203L/fi
Application granted granted Critical
Publication of FI110097B publication Critical patent/FI110097B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI952203A 1994-05-10 1995-05-08 5-(3-imidatso[4,5-b]pyridin-1-yyli-3-fenyyli-akryloyylioksi)-sykloheksaanikarboksyylihappojohdannaiset, niiden käyttö ja yhdisteitä sisältävät lääkeaineet FI110097B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4416433 1994-05-10
DE4416433A DE4416433A1 (de) 1994-05-10 1994-05-10 Cyclohexan-Derivate, Verfahren zu ihrer Herstellung und die Verwendung der Verbindungen zur Behandlung von Krankheiten

Publications (3)

Publication Number Publication Date
FI952203A0 true FI952203A0 (fi) 1995-05-08
FI952203L FI952203L (fi) 1995-11-11
FI110097B FI110097B (fi) 2002-11-29

Family

ID=6517746

Family Applications (1)

Application Number Title Priority Date Filing Date
FI952203A FI110097B (fi) 1994-05-10 1995-05-08 5-(3-imidatso[4,5-b]pyridin-1-yyli-3-fenyyli-akryloyylioksi)-sykloheksaanikarboksyylihappojohdannaiset, niiden käyttö ja yhdisteitä sisältävät lääkeaineet

Country Status (22)

Country Link
US (1) US5739147A (fi)
EP (1) EP0682024B1 (fi)
JP (1) JP3790564B2 (fi)
KR (1) KR100355690B1 (fi)
CN (1) CN1043643C (fi)
AT (1) ATE187454T1 (fi)
AU (1) AU683148B2 (fi)
CA (1) CA2149007C (fi)
CZ (1) CZ288443B6 (fi)
DE (2) DE4416433A1 (fi)
DK (1) DK0682024T3 (fi)
ES (1) ES2141276T3 (fi)
FI (1) FI110097B (fi)
GR (1) GR3032519T3 (fi)
HU (1) HU220865B1 (fi)
NO (1) NO304314B1 (fi)
NZ (1) NZ272082A (fi)
PL (1) PL180074B1 (fi)
RU (1) RU2140416C1 (fi)
TW (1) TW421648B (fi)
UA (1) UA41340C2 (fi)
ZA (1) ZA953726B (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW526202B (en) 1998-11-27 2003-04-01 Shionogi & Amp Co Broad spectrum cephem having benzo[4,5-b]pyridium methyl group of antibiotic activity
DK1741446T3 (da) 2000-01-21 2008-06-02 Novartis Pharma Ag Kombinationer indeholdende dipeptidylpeptidase-IV-inhibitorer og antidiabetiske midler
AU2002254940A1 (en) * 2001-03-12 2002-09-24 Novartis Pharma Gmbh Combination of nateglinide or repaglinide with at least one further antidiabetic compound
FR2852957B1 (fr) * 2003-03-31 2005-06-10 Sod Conseils Rech Applic Nouveaux derives d'imidazo-pyridine et leur utilisation en tant que medicament
CN101309689B (zh) 2005-09-14 2012-10-10 武田药品工业株式会社 用于治疗糖尿病的二肽基肽酶抑制剂
WO2011041293A1 (en) 2009-09-30 2011-04-07 Takeda Pharmaceutical Company Limited Pyrazolo [1, 5-a] pyrimidine derivatives as apoptosis signal-regulating kinase 1 inhibitors
US8802695B2 (en) 2010-02-03 2014-08-12 Takeda Pharmaceutical Company Limited Apoptosis signal-regulating kinase 1 inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60243016A (ja) * 1984-05-17 1985-12-03 Tsumura Juntendo Inc 抗インフルエンザウイルス剤
TW255880B (fi) * 1992-09-09 1995-09-01 Hoechst Ag
TW399041B (en) * 1992-09-09 2000-07-21 Hoechst Ag Substituted cyclohexane derivatives, the preparation and the use for treating diseases
DE4408082A1 (de) * 1994-03-10 1995-09-14 Hoechst Ag Substituierte Propan-Derivate, Verfahren zu ihrer Herstellung und die Anwendung der Verbindungen zur Behandlung von Krankheiten
DE4413402A1 (de) * 1994-04-18 1995-10-19 Hoechst Ag Verfahren zur Herstellung von Zwischenprodukten für die Synthese von Glucose-6-Phosphatase-Inhibitoren sowie neue Zwischenprodukte

Also Published As

Publication number Publication date
CZ119595A3 (en) 1995-12-13
RU95107147A (ru) 1997-03-20
EP0682024B1 (de) 1999-12-08
RU2140416C1 (ru) 1999-10-27
HK1011989A1 (en) 1999-07-23
EP0682024A1 (de) 1995-11-15
CA2149007C (en) 2005-07-26
GR3032519T3 (en) 2000-05-31
KR950032191A (ko) 1995-12-20
JP3790564B2 (ja) 2006-06-28
HU220865B1 (en) 2002-06-29
ATE187454T1 (de) 1999-12-15
PL180074B1 (pl) 2000-12-29
ZA953726B (en) 1996-01-11
NZ272082A (en) 1996-09-25
NO304314B1 (no) 1998-11-30
DK0682024T3 (da) 2000-05-22
FI110097B (fi) 2002-11-29
TW421648B (en) 2001-02-11
NO951820L (no) 1995-11-13
KR100355690B1 (ko) 2002-12-26
CA2149007A1 (en) 1995-11-11
FI952203L (fi) 1995-11-11
DE4416433A1 (de) 1995-11-16
JPH07330767A (ja) 1995-12-19
AU683148B2 (en) 1997-10-30
UA41340C2 (uk) 2001-09-17
CN1118782A (zh) 1996-03-20
CN1043643C (zh) 1999-06-16
DE59507361D1 (de) 2000-01-13
ES2141276T3 (es) 2000-03-16
PL308521A1 (en) 1995-11-13
AU1792395A (en) 1995-11-16
CZ288443B6 (en) 2001-06-13
HUT71797A (en) 1996-02-28
NO951820D0 (no) 1995-05-09
US5739147A (en) 1998-04-14

Similar Documents

Publication Publication Date Title
EP1095665A4 (en) Wound healing composition, wound dressing and wound treatment method
ES2059069T3 (es) Nuevos derivados de 1-alcoxi-(2-acilamino-etil)-naftalenos y su procedimiento de preparacion.
DK0416410T3 (da) Piperaziniocephalosporiner
ATE247114T1 (de) Serotonergische modulatoren
ATE160148T1 (de) Sonnenfilter, diese enthaltende kosmetische lichtschutzzusammensetzungen sowie deren verwendung
FI952203A0 (fi) Sykloheksaanijohdannaiset, menetelmä niiden valmistamiseksi ja yhdisteiden käyttö sairauksien hoitamiseksi
ATE118523T1 (de) Flüssigkristall-racematmischung, flüssigkristallzusammensetzung und flüssigkristallelement, verfahren zur herstellung und verwendung.
ATE202704T1 (de) Verwendung eines natrium- oder lysiniumsalzes von crotonsäureamidderivaten zur herstellung eines arzneimittels zur behandlung von krebserkrankungen
FI955085A0 (fi) Uudet diosmetiiniyhdisteet, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
ATE179168T1 (de) Substituierte spiroverbindungen zur behandlung von entzündungen
DE69302087D1 (de) Trazodone alkyl derivate mit zns wirkung
DE3688161D1 (de) Gegebenenfalls etherifizierte oder esterifizierte in stellung 2 substituierte 4-oh-chinolincarbonsaeurederivate, verfahren und zwischenprodukte zu ihrer herstellung, ihre anwendung als arzneimittel und diese enthaltende zubereitungen.
PT816358E (pt) Amidas de acido 4-amino-2-ureido-pirimidina-5-carboxilico, processos para a sua preparacao, medicamentos contendo estes compostos e sua utilizacao
DE69232776D1 (de) Verfahren zur Herstellung von Cephalosporinen und Zwischenverbindungen in diesem Verfahren
ATE205189T1 (de) Benzolsulfonylamin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
ATE17474T1 (de) Verfahren zur herstellung von cystamin-derivaten mit onkostatischer wirkung.
IT1244649B (it) Procedimento per il trattamento di substrati com composti aromatici contenenti gruppi solfo, composizioni contenenti tali composti e loro preparazione
ATE137973T1 (de) Phospholipide zur behandlung der multiplen sklerose

Legal Events

Date Code Title Description
MA Patent expired